These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 348315)

  • 21. [Clinical evaluation of Bleomycin in tumor pateints].
    Rieche K; Matthias M
    Arch Geschwulstforsch; 1973; 41(3):232-40. PubMed ID: 4126058
    [No Abstract]   [Full Text] [Related]  

  • 22. Hypercalcemic crisis in neoplastic diseases: management with mithramycin.
    Elias EG; Evans JT
    Surgery; 1972 Apr; 71(4):631-5. PubMed ID: 4259864
    [No Abstract]   [Full Text] [Related]  

  • 23. Phase II evaluation of chlorozotocin in patients with non-small cell carcinoma of the lung.
    Casper ES; Gralla RJ
    Cancer Treat Rep; 1979 Apr; 63(4):549-50. PubMed ID: 156068
    [No Abstract]   [Full Text] [Related]  

  • 24. Phase II trial of esorubicin in patients with advanced colorectal carcinoma.
    Fiore J; Kemeny N; Raymond V; Young C
    Cancer Treat Rep; 1986 Oct; 70(10):1241-2. PubMed ID: 3530453
    [No Abstract]   [Full Text] [Related]  

  • 25. Preliminary phase II study of adriamycin (ADM) in patients with non-small cell lung cancer (NSCLC).
    Fujita J; Saijo N; Eguchi K; Shinkai T; Tominaga K; Sasaki Y; Sakurai M; Futami H; Ishihara J; Takahashi H
    Jpn J Clin Oncol; 1985 Jun; 15(2):365-8. PubMed ID: 4021119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study of spirogermanium in advanced (extensive) non-small cell lung cancer.
    Dhingra HM; Umsawasdi T; Chiuten DF; Murphy WK; Holoye PY; Spitzer G; Valdivieso M
    Cancer Treat Rep; 1986 May; 70(5):673-4. PubMed ID: 3708617
    [No Abstract]   [Full Text] [Related]  

  • 27. Piperazinedione in metastatic renal carcinoma.
    Pasmantier MW; Coleman M; Kennedy BJ; Eagan R; Carolla R; Weiss R; Leone L; Silver RT
    Cancer Treat Rep; 1977 Dec; 61(9):1731-2. PubMed ID: 340039
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase II evaluation of acivicin in lung cancer: a Southeastern Cancer Study Group Trial.
    Kramer BS; Birch R; Greco A; Prestridge K; Johnson R
    Cancer Treat Rep; 1986 Aug; 70(8):1031-2. PubMed ID: 3524833
    [No Abstract]   [Full Text] [Related]  

  • 29. Vindesine in the treatment of squamous cell carcinoma, adenocarcinoma, and large cell carcinoma of the lung.
    Osterlind K; Hørbov S; Dombernowsky P; Rørth M; Hansen HH
    Cancer Treat Rep; 1982 Feb; 66(2):305-9. PubMed ID: 7055816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II evaluation of bisantrene in patients with advanced non-small cell lung carcinoma.
    Feld R; Evans WK; Shepherd FA; Deboer G; Ottema B
    Cancer Treat Rep; 1985 Feb; 69(2):209-10. PubMed ID: 3971392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical trial of rubidazone in advanced squamous cell carcinoma of the lung and adenocarcinoma of the large intestine.
    Fraile RJ; Samson MK; Buroker TR; O'Bryan R; Baker LH; Vaitkevicius VK
    Cancer Treat Rep; 1978 Oct; 62(10):1599-601. PubMed ID: 361229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II trial of 4-demethoxydaunorubicin in patients with non-small cell lung cancer.
    Joss RA; Obrecht JP; Alberto P; Siegenthaler P; VanHelvoirt A; Cavalli F
    Cancer Treat Rep; 1984 Mar; 68(3):563-4. PubMed ID: 6322990
    [No Abstract]   [Full Text] [Related]  

  • 33. Phase II study of vindesine in patients with non-small cell lung cancer.
    Fujita J; Saijo N; Eguchi K; Shinkai T; Tominaga K; Sasaki Y; Futami H; Sakurai M; Ishihara J; Takahashi H
    Jpn J Cancer Res; 1985 Sep; 76(9):902-5. PubMed ID: 2997097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initial clinical study with pyrazofurin.
    Ohnuma T; Holland JF
    Cancer Treat Rep; 1977; 61(3):389-94. PubMed ID: 872139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Preliminary phase II study of cis-Dichlorodiammineplatinum (II) in patients with non-small cell carcinoma of the lung and metastatic pulmonary tumor].
    Tominaga K; Saijo N; Eguchi K; Shinkai T; Shimizu E
    Gan No Rinsho; 1984 Sep; 30(11):1344-50. PubMed ID: 6094880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II evaluation of aclarubicin in advanced breast cancer: a Southeastern Cancer Study Group trial.
    Gockerman JP; Raney M; Logan T
    Cancer Treat Rep; 1985 Sep; 69(9):1029-30. PubMed ID: 3861247
    [No Abstract]   [Full Text] [Related]  

  • 37. Phase II study of cis-diamminedichloroplatinum in patients with non-small cell lung cancer.
    Fujita J; Saijo N; Eguchi K; Shimizu E; Shinkai T; Tominaga K; Sasaki Y; Futami H; Sakurai M; Hoshi A
    Jpn J Cancer Res; 1985 May; 76(5):420-3. PubMed ID: 3924714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II trial of anaxirone in advanced non-small cell lung cancer.
    Fiebig HH; Henss H; Arnold H; von Bültzingslöwen F; Klee M; Queisser W; Peukert M
    Cancer Treat Rep; 1987 May; 71(5):539-40. PubMed ID: 3567979
    [No Abstract]   [Full Text] [Related]  

  • 39. [New antineoplastic agent, bleomycin, with special reference to its notable effect on squamous cell carcinoma].
    Ichikawa T
    Nihon Rinsho; 1969 Jun; 27(6):1618-26. PubMed ID: 5816830
    [No Abstract]   [Full Text] [Related]  

  • 40. A clinical trial of pyrazofurin in combination with 5-azacytidine in acute adult nonlymphocytic leukemia.
    Van Echo DA; Chiuten DF; Markus S; Wiernik PH
    Cancer Clin Trials; 1981; 4(2):129-33. PubMed ID: 6166406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.